Research School CAPHRI, Department of Health, Ethics, and Society, Maastricht University, Maastricht, The Netherlands.
Tranzo (Scientific Centre for Care and Welfare), Tilburg University, Tilburg, The Netherlands.
J Eval Clin Pract. 2019 Jun;25(3):390-397. doi: 10.1111/jep.12900. Epub 2018 Mar 6.
RATIONALE, AIMS, AND OBJECTIVES: This paper examines a remarkable dispute between Dutch insurers, hospitals, doctors, and patients about a set of quality indicators. In 2013, private insurers planned to drastically reform Dutch emergency care using quality indicators they had formulated drawing from clinical guidelines, RCTs, and systematic reviews. Insurers' plans caused much debate in the field of emergency care. As quality indicators have come to play a more central role in health care governance, the questions what constitutes good evidence for them, how they ought to be used, and who controls them have become politically and morally charged. This paper is a case study of how a Dutch public knowledge institution, the National Health Care Institute, intervened in this dispute and how they addressed these questions.
We conducted ethnographic research into the knowledge work of the National Health Care Institute. Research entailed document analysis, participant observation, in-depth conversations, and formal interviews with 5 key-informants.
The National Health Care Institute problematized not only the evidence supporting insurers' indicators, but also-and especially-the scope, purpose, and use of the indicators. Our analysis shows the institute's struggle to reconcile the technical rationality of quality indicators with their social and political implications in practice. The institute deconstructed quality indicators as national standards and, instead, promoted the use of indicators in dialogue with stakeholders and their local and contextual knowledge.
Even if quality indicators are based on scientific evidence, they are not axiomatically good or useful. Both proponents and critics of Evidence-based Medicine always feared uncritical use of evidence by third parties. For non-medical parties who have no access to primary care processes, the type of standardized knowledge professed by Evidence-based Medicine provides the easiest way to gain insights into "what works" in clinical practice. This case study reminds us that using standardized knowledge for the management of health care quality requires the involvement of stakeholders for the development and implementation of indicators, and for the interpretation of their results.
背景、目的和目标:本文研究了荷兰保险公司、医院、医生和患者之间围绕一套质量指标展开的一场引人注目的争议。2013 年,私人保险公司计划利用从临床指南、RCT 和系统评价中提取的质量指标对荷兰急救护理进行重大改革。保险公司的计划在急救护理领域引起了广泛争议。随着质量指标在医疗保健治理中发挥越来越重要的作用,关于什么构成了它们的良好证据、如何使用它们以及谁控制它们的问题已经在政治和道德层面上引起了争议。本文是对荷兰一家公共知识机构——国家卫生保健研究所(National Health Care Institute)如何介入这场争议以及如何处理这些问题的案例研究。
我们对国家卫生保健研究所的知识工作进行了民族志研究。研究方法包括文件分析、参与式观察、深入访谈以及对 5 名关键知情者的正式访谈。
国家卫生保健研究所不仅对支持保险公司指标的证据提出了质疑,而且——尤其是——对指标的范围、目的和用途提出了质疑。我们的分析表明,该研究所一直在努力调和质量指标的技术理性与其在实践中的社会和政治影响。该研究所在国家层面解构了质量指标,并提倡在与利益相关者及其地方和背景知识进行对话的过程中使用指标。
即使质量指标是基于科学证据的,它们也不是理所当然的好或有用的。循证医学的支持者和批评者都担心第三方对证据的不加批判的使用。对于无法接触到初级保健过程的非医学方来说,循证医学所倡导的标准化知识为深入了解临床实践中的“有效方法”提供了最简单的途径。这个案例研究提醒我们,使用标准化知识来管理医疗质量需要利益相关者的参与,以制定和实施指标,并解释其结果。